Biopharmas raising money in public or private financings, including: Acacia, Equillium, Oncology Venture, Optinose, PDS.

Immunoscape Ltd. closed an $11 million global equity financing round led by U.S.-based venture firm Anzu Partners along with University of Tokyo Edge Capital in Japan, and Indonesia's NPR Holdings. The company plans to use the funds to ramp up its immune profiling technology platform, which performs deep T-cell analysis, and expand partnerships to develop vaccines for COVID-19 and other viruses as well as targeted oncology therapies.

Cansino Biologics Inc. launched its second pre-revenue share offering on Aug. 13, reaping ¥5.2 billion ($749 million) from Shanghai’s STAR market.

Med-tech firms raising money in public or private financings, including: Assure Holdings.

Biopharmas raising money in public or private financings, including: Adverum, Bone, Organicell, Seres.

Med-tech firms raising money in public or private financings, including: Mobileodt, Neovasc, Reify Health, Pacific Biosciences of California, Personalis, Quanterix.

Biopharmas raising money in public or private financings, including: Adverum, Horizon, Inhibrx, Nymox, Omeros, Seres, Trevena.